Is TNH-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TNH-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TNH-R (THB38) is trading above our estimate of fair value (THB23.42)
Significantly Below Fair Value: TNH-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TNH-R?
Key metric: As TNH-R is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for TNH-R. This is calculated by dividing TNH-R's market cap by their current
earnings.
What is TNH-R's PE Ratio?
PE Ratio
15.7x
Earnings
฿434.92m
Market Cap
฿6.84b
TNH-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: TNH-R is good value based on its Price-To-Earnings Ratio (15.7x) compared to the TH Healthcare industry average (21.5x).
Price to Earnings Ratio vs Fair Ratio
What is TNH-R's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
TNH-R PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
15.7x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate TNH-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.